Galmed Pharmaceuticals Ltd. buy Roth Mkm
Start price
20.10.23
/
50%
€0.39
Target price
20.10.24
€70.85
Performance (%)
-5.18%
Price
16.05.24
€0.37
Summary
This prediction is currently active. With a performance of -5.18%, the BUY prediction by Roth_Mkm is trending in the wrong direction. This prediction currently runs until 20.10.24. The prediction end date can be changed by Roth_Mkm at any time. Roth_Mkm has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Galmed Pharmaceuticals Ltd. | 1.105% | 1.105% |
| iShares Core DAX® | -0.051% | 4.829% |
| iShares Nasdaq 100 | 1.659% | 2.417% |
| iShares Nikkei 225® | 0.658% | -2.173% |
| iShares S&P 500 | 0.964% | 2.547% |
Comments by Roth_Mkm for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $75.00 price target on the stock.
Ratings data for GMED provided by MarketBeat